Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Teva Announces Signing of New $3B Syndicated Revolving Credit Line

Paul Quintaro, Benzinga Staff Writer
December 18, 2012 12:26 PM
+ Follow
Print
Email
Tickers: TEVA
Benzinga Share:

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new five-year, $3.0 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted in: News, Financing

 

Around the Web, We're Loving...

Boston Bomb Probe Focuses on Bags and Pressure Cooker
Bank of America Falls On Q1 Results, Mortgage Settlement
What You Should Know About GOOG

Most Popular

Google Drive Goes Down, Halting Productivity for Many Users
Wii U Sales Plummet in March
Apple Broke Down - What do the Charts Say Now?
Forget The Housing Crash, This Market Has Been Booming
Allergan Receives Complete Response Letter from the FDA for LEVADEX
UPDATE: Jefferies Lowers PT on United States Steel Corporation on Reduced 2013 Steel Estimates

Related Articles (TEVA)

Teva Says New Data from Phase III Trial of Milprosa Showed Comparable Multiple Pregnancy Rates
Short Sellers Move Out of Amgen, Celgene, Pharmacyclics
Another Israel ETF Could Be On The Way
Ichiro Kikushige Named CEO of Teva Seiyaku, Japan
Yoo Suk Hong Named CEO of Teva-Handok
Teva-Lonza JV Says Evaluating Biosimilars Opportunities

Partner Network

Get Benzinga's News Delivered Free

Posts by Paul Quintaro

Benzinga Professional

Subscribe